ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,370Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 30

$708K Total Retail Price of All Prescriptions

Rank: 9 out of 30

436 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 436 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

19% of this provider’s 436 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 6,779 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 454 333 1 1
HYDROCODONE-ACETAMINOPHEN 437 127 S3 2 9
OMEPRAZOLE 363 257 3 2
LISINOPRIL 311 226 4 4
AMLODIPINE BESYLATE 264 210 5 7
METFORMIN HCL 251 209 6 11
LEVOTHYROXINE SODIUM 238 163 7 3
METOPROLOL TARTRATE 236 199 8 6
GABAPENTIN 233 139 9 18
FUROSEMIDE 231 153 10 5
ATORVASTATIN CALCIUM 227 188 11 10
CITALOPRAM HBR 139 46 12 16
CELEBREX 117 95 13 48
TRAMADOL HCL 116 12 14 32
SERTRALINE HCL 114 95 15 26
MELOXICAM 113 61 16 60
SPIRIVA 112 64 17 57
AZITHROMYCIN 105 72 18 44
IBUPROFEN 100 58 19 88
HYDROCHLOROTHIAZIDE 99 63 20 15
PANTOPRAZOLE SODIUM 97 54 21 21
AMLODIPINE BESYLATE-BENAZEPRIL 95 61 22 56
ADVAIR DISKUS 87 71 23 31
WARFARIN SODIUM 85 54 24 8
VENTOLIN HFA 83 18 25 83
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 49 26 53
POTASSIUM CHLORIDE 79 54 27 12
OXYCODONE HCL 76 54 S2 28 57
AMOXICILLIN 74 47 29 121
ALENDRONATE SODIUM 72 59 30 38
DIOVAN HCT 71 68 31 49
TRIAMCINOLONE ACETONIDE 70 48 32 95
CLOPIDOGREL 70 56 32 20
CYMBALTA 69 19 34 99
DEXILANT 69 44 34 125
JANUVIA 65 54 36 61
DIGOXIN 64 52 37 24
CYCLOBENZAPRINE HCL 63 14 R 38 121
TAMSULOSIN HCL 63 50 38 14
DIOVAN 62 43 40 28
BENICAR 62 48 40 93
NAPROXEN 60 51 42 186
GLYBURIDE-METFORMIN HCL 59 21 R 43 187
FENTANYL 59 39 S2 43 50
FLUOXETINE HCL 59 40 43 85
CIPROFLOXACIN HCL 57 41 46 43
MORPHINE SULFATE ER 55 12 S2 47 135
BENICAR HCT 54 27 48 120
TRICOR 53 34 49 69
ZOLPIDEM TARTRATE 53 34 49 46
VENLAFAXINE HCL ER 53 26 49 71
CARVEDILOL 53 37 49 17
ALLOPURINOL 51 42 53 35
RANITIDINE HCL 51 21 53 42
PLAVIX 50 45 55 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.